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Abstract: A test based on tapering is proposed for use in testing a global
linear hypothesis under a functional linear model. The test statistic is con-
structed as a weighted sum of squared linear combinations of Fourier coef-
ficients, a tapered quadratic form, in which higher Fourier frequencies are
down-weighted so as to emphasize the smooth attributes of the model. A
formula is QOPTn = n
∑pn
j=1
j−1/2‖Y n,j‖2. Down-weighting by j−1/2 is
selected to achieve adaptive optimality among tests based on tapering with
respect to its “rates of testing,” an asymptotic framework for measuring a
test’s retention of power in high dimensions under smoothness constraints.
Existing tests based on truncation or thresholding are known to have su-
perior asymptotic power in comparison with any test based on tapering;
however, it is shown here that high-order effects can be substantial, and
that a test based on QOPTn exhibits better (non-asymptotic) power against
the sort of alternatives that would typically be of concern in functional data
analysis applications. The proposed test is developed for use in practice,
and demonstrated in an example application.
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1. Introduction
The subject of this article is the functional linear model and functional linear
hypothesis, both cornerstones functional data analysis (FDA) methodologies.
This model is described as a sample of independent random functions (some-
times called curves or profiles), which here will be taken to have a common
one-dimensional domain, (a, b], and real-valued response. To facilitate study of
asymptotic properties, the present investigation will adopt a replicated func-
tional linear model, in which each of N response points of dimension P is repli-
cated n times. In matrix form, the i’th replication is
dY i(t) = Xβ(t)dt+ σdǫi(t), (1.1)
for i = 1, . . . , n, where Y i(t) = [Yi,1(t), . . . , Yi,N (t)]
T is a functional vector
of responses on t ∈ (a, b], and X = [x1, . . . ,xN ]T is a N × P “essence” re-
gressor matrix, assumed of full column-rank, which stores the values of ex-
planatory variables at which the response functions are measured. The vector
β(t) = [β1(t), . . . , βP (t)]
T is a P × 1 functional vector of regression coefficients,
and the ǫi are independent and identically distributed functional error vectors;
each ǫi(t) = [ǫi,1(t), . . . , ǫi,N (t)]
T is a vector of independent and identically dis-
tributed error functions, for which E[ǫi,k(t)] = 0 and V [ǫi,k(t)] = 1 for each (i, k)
and t, and which are stationary on t ∈ (a, b]. The functional linear hypothesis
is H0 : L
Tβ(t) = 0 for all t ∈ (a, b] against a general alternative, where L is a
P × ν hypothesis matrix of full column-rank. (Use of the symbol ν is to reflect
the degrees of freedom in a standard test of such a hypothesis in the analogous
univariate situation.)
After some initial preprocessing, functional data may typically be repre-
sented by a discrete, high-dimensional model. Such representations are made
here using Fourier decomposition, whose advantage in FDA is not only to dis-
cretize the model but also to decorrelate the error structure and offer mean-
ingful descriptive summarization. This is demonstrated on an existing data set
in Section 2. (See also Fan and Lin, 1998, Spitzner, Marron, and Essick, 1998,
Spitzner and Woodall, 2003, and Spitzner, 2008B for further demonstrations in
FDA.) Also laid out in that section is how, taking into consideration the specific
L, data collected under the model (1.1) may be translated to that of the model
Y n,j = θj + n
−1/2en,j , (1.2)
for j = 1, . . . , pn, where pn represents some (high) maximum number of dimen-
sions to be accounted for at a given n. The statistics Y n,j = [Yn,j1, . . . , Yn,jν ]
T
are ν-dimensional discrete data vectors, each entry of which a linear com-
bination Fourier coefficients (defined by a distinct column of L) that partly
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summarizes the information relevant to the specific null hypothesis. The θj =
[θj1, . . . , θjν ]
T are mean vectors, and the en,j = [en,j1, . . . , en,jν ]
T are zero-
mean, unit-covariance error-vectors such that the en,jk are independent across
k. (Across j, however, small correlations among the en,jk are possible.) The
functional linear hypothesis translates to
H0 : θj = 0 for j = 1, . . . , pn versus H1 : not H0, (1.3)
in which the matrix L has been absorbed into the transformation from (1.1) to
(1.2).
A typical assumption made in FDA is that the functional parameter β(t) in
(1.1) is somehow “smooth.” From an intuitive standpoint, this means that the
β1(t), . . . , βP (t) are each taken to be a conglomeration of mainly large-scale,
sweeping shapes, which are represented by low-frequency Fourier components.
For rigorous analysis, smoothness is expressed more technically in Section 3
by restricting β(t) to a Sobolev class. At any rate, a key issue in testing is
how to exploit the smoothness assumption, so as not to waste statistical power
attempting to distinguish the “rougher” aspects of the model (i.e., the small-
scale wiggly shapes). This is especially important for testing in high-dimensions,
where the vastness of the parameter space requires a careful management of
power.
The transformation to the discrete model (1.2) typically assigns smaller j to
model-components associated with smoother functional attributes. Noting this,
one would want a test that focuses power primarily on the model’s lower-indexed
components. One class of tests that do this is defined by test statistics of the
form
Qn = n
pn∑
j=1
wn,j‖Y n,j‖2, (1.4)
where each 0 < wn,j ≤ 1 and wn,j → 0 as j → ∞ to emphasize the Y n,j with
smaller j. The particular test of interest in this article is defined by the weight
setting wn,j = j
−1/2, which rewrites (1.4) as QOPTn = n
∑pn
j=1 j
−1/2‖Yn,j‖2.
This technique of managing power by direct down-weighting, as in (1.4), shall be
referred to as “tapering.” Detailed asymptotic power properties of tests based on
tapering are deduced in Spitzner (2008A), some of whose results are reproduced
in Section 3. There, it is shown that QOPTn manages asymptotic power in an
optimal way among test statistics of the form (1.4).
The asymptotic performance criteria used in Spitzner (2008A) and adopted
here are taken from “rates of testing” theory, a framework articulating the rate
at which power is retained in high-dimensional testing problems under geometric
smoothness constraints. Its basic components are laid out in Ingster (1993),
Spokoiny (1996), Lepski and Spokoiny (1999), Horowitz and Spokoiny (2001),
and Gayraud and Pouet (2005), among others. Relevant criteria are described
fully in Section 3. Within this context, the problem of selecting the wn,j in
(1.4) for good asymptotic power would be aptly described as constrained rate-
optimization among tests based on tapering, for which QOPTn is a solution.
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There are, however, two types of asymptotic optimality to consider, and it is
known that any test based on tapering is suboptimal with respect to the type
that is more relevant for consideration in practice. Specifically, Ingster (1993)
and Spokoiny (1996) respectively deduce “minimax” and “adaptive-minimax”
rates, which bound the performance of any test with respect to an adopted
smoothness geometry. The former rate defines a stronger form of asymptotic
optimality, but the latter “adaptive” type is the one more practically relevant.
It is well established that tests based on tapering can achieve Ingster’s min-
imax rate of testing (e.g., Ingster (1993) and Fan, Zhang, and Zhang (2001)
provide two distinct examples), but Spitzner (2008A) deduces the suboptimal-
ity of any test based on tapering, including that based on QOPTn , with respect
to Spokoiny’s adaptive-minimax criterion.
Existing tests that are known to achieve adaptive minimaxity are based
on the alternative test-construction techniques of “truncation” or “threshold-
ing.” Spokoiny (1996) provides an adaptive-minimax test based on thresholding,
and Fan, Zhang, and Zhang (2001) establish the adaptive minimaxity of Fan’s
(1996) “adaptive Neyman test,” a test based on truncation. Details of these
tests are provided in Section 4. Both have been developed for use in FDA in
Fan and Lin (1998) and Abramovich et al. (2002).
Despite its asymptotic suboptimality, the test based on QOPTn is demon-
strated in Section 4 to retain good and even superior power over the adaptive-
minimax tests above in non-asymptotic, practically realistic FDA settings, il-
lustrating that the improvements offered by thresholding or truncation, though
guaranteed, may arise quite slowly asymptotically. That is, the evidence of this
article suggests that, among tapering, truncation, and thresholding, the most
powerful tests in typical FDA applications are constructed by tapering!
A novel aspect of this article is that it highlights a distinction between the
asymptotic setup of FDA and that of other high-dimensional problems involving
smoothness constraints, such as goodness-of-fit testing, within which many of
the existing high-dimensional tests were first developed. The particular distinc-
tion has to do with the dependence of the dimensionality parameter, pn, on the
sample-size parameter n. In non-FDA scenarios, there is typically an explicit
connection between these two parameters (often pn = n), whereas in FDA the
connection is largely hypothetical, and one typically has little or no control over
the rate at which pn increases. Accordingly, an important concern in FDA is
the sensitivity of test performance on the rate of pn →∞. It shall be seen that
the optimality property of the test based on QOPTn is robust in this regard.
1.1. Organization
This paper is organized as follows. Section 2 presents an applied data example,
which demonstrates the transformation from (1.1) to (1.2) and the test based on
QOPTn . This will provide grounding and intuition for subsequent discussion. The
setup and relevance of asymptotic analysis in FDA is discussed in that section
as well. Section 3 defines rates-of-testing criteria and presents the paper’s main
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theoretical results. Section 4 gives details of several existing high-dimensional
tests, and reports on empirical comparisons carried out by simulation. Conclud-
ing discussion appears in Section 5, in which the importance of studying tests
based on tapering in FDA is further elaborated.
2. Functional data analysis and its asymptotic framework
Let us begin discussion with an analysis of the Canadian temperature data of
Ramsay and Silverman (2005, ch. 13) under a functional linear model. (The data
are available in a supplemental website to the book.) Subsequently, a general
asymptotic setup for functional data analysis will be laid out.
2.1. An example data set
The Canadian temperature data consist of daily mean-temperature profiles
across the year at 31 weather stations in three regions of Canada: there are
M1 = 14 “Atlantic” stations, M2 = 5 “Pacific” stations and M3 = 12 “Conti-
nental” stations. The raw measurements are displayed in the top panels of Figure
1. (The original data set analyzed by Ramsay and Silverman also includes three
stations in an additional “Arctic” region, and one additional Atlantic station,
at “Schefferville.” For the present analysis it makes sense to have set aside the
Arctic stations since there are so few of them, and the Schefferville station since
its location is of unusually high latitude relative to the other Atlantic stations.)
Ramsay and Silverman remark that the region-effects seen in these data are
“more complex than the constant or even sinusoidal effects that one might ex-
pect,” but note specifically that the Pacific stations tend to have warmer winter
temperatures and Continental stations tend to have colder winter temperatures,
while all regions’ summer temperatures tend close to the average. The latter ob-
servations refer to large-scale attributes of the temperature profiles, and it will
be presumed that these and other large-scale attributes are of primary interest.
Nevertheless, smaller-scale, “more complex” attributes are not to be ignored;
we want a systematic way to explore essentially all aspects of the data. Fourier
decomposition provides just such a technique, one that is furthermore most ap-
propriate for data such as yearly temperature profiles whose attributes tend to
be periodic.
2.2. Fourier decomposition
The notation used in this analysis will parallel that of Section 1, but, for sim-
plicity, without the subscript n, thereby ignoring any replication concepts until
further ideas are laid down. Set M = M1 +M2 +M3 = 31 and denote by Yk(t)
the measurement of the k’th station at time t within a typical year: the mea-
surement times are t1, . . . , tr, where t1 is January 1, r = 365, and tl = l, so that
tl+1 − tl is one day. Next define the Fourier basis functions on (0, 365] accord-
ing to ψ1(t) = 1, ψ2j(t) = sin(jπ(2t/r − 1)), and ψ2j+1(t) = cos(jπ(2t/r − 1))
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Fig 1. Canadian temperature data for weather stations in the Atlantic, Pacific, and Conti-
nental regions. The top panels plot average temperatures Yk(t) across the year, and the bottom
panels plot individual sets of Fourier coefficients Y ∗
jk
for j = 1, . . . , 5.
for j = 1, 2, . . . The j’th Fourier coefficient of the k’th station is then Y ∗jk =
r−1
∑r
l=1 Yk(tl)ψj(tl), which gives the j’th coefficient of a multiple regression of
Yk(tl) across t1, . . . , tr onto any finite set of regressors ψj(tl) across t1, . . . , tr.
Coefficients associated with the first few ψj are shown in the bottom panels of
Figure 1, centered and scaled for each j so that the mean and sum of squares
of the displayed Y ∗jk match common values.
Consider, for instance, that the shapes of ψ1(t) = 1 and ψ3(t) = cos(π(2t/r−
1)) convey interpretations whereby Y ∗1k measures the k’th station’s yearly av-
erage temperature and Y ∗3k measures its differential between the winter and
summer temperatures. With this in mind, observe from the bottom panels of
Figure 1 that the Y ∗1k tend to be larger for the Pacific region and smaller for
the Continental region, while the Y ∗3k tend to be smaller for the Pacific region
and larger for the Continental region. This reflects the observations made by
Ramsay and Silverman: between these two regions, the yearly average temper-
ature of the Pacific region is warmer (as reflected in the Y ∗1k) and there is a
smaller differential between the winter and summer temperatures (as reflected
in the Y ∗3k). Each of the remaining sets of coefficients describe a distinct at-
tribute of these data. For instance, the Y ∗2k describe asymmetries between the
spring and fall transition periods, and the Y ∗jk with larger j summarize finer
periodic attributes of the stations’ yearly profiles.
Fourier decomposition of these data is not discussed in Ramsay and Silverman
(2005) itself, but it is in the book’s supplemental internet materials, within which
there appears the remark: “it was decided that 65 basis functions captured
enough of the detail in the temperature data . . . ,” referring to Fourier basis
functions. The present analysis will follow this guideline and consider just the
Fourier coefficients Y ∗jk with j = 1, . . . , 65.
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Fig 2. Scatterplots of Y ∗
1k
and Y ∗
41k
by latitude, with region-specific fitted regression lines.
The Atlantic stations are indicated by dots (•), the Pacific stations by circles (◦), and the
Continental stations by asterisks (∗).
2.3. Linear models and testing
Ramsay and Silverman (2005) treat the temperature profiles by an elementary
multi-group functional model, Yk(g,l)(t) = µg(t) + ǫk(g,j)(t), where k = k(g, l)
indexes the l’th station of region g, µg(t) is the mean temperature profile for the
g’th region, and ǫk(g,j)(t) are random errors. Their analysis concludes that there
are indeed vast differences in temperature profiles among the regions. Consider,
however, that one would expect latitude to explain some substantial portion of
the variation in temperature from station to station, and moreover that it is
surely possible for the dependency of temperature on latitude to change from
region to region. Accordingly, the model considered here is an extension of the
multi-group model that incorporates latitude as a covariate in such a way as to
allow for differences in both intercept and slope across regions. Denoting by xk
the latitude of the k’th station, and writing x¯ = M−1
∑M
k=1 xk, the extended
model is Yk(g,l)(t) = µg(t) + βg(t)(xk(g,j) − x¯) + ǫk(g,j)(t), a functional linear
model with P = 6 regression parameters, µg(t) and βg(t) for g = 1, 2, 3. From
this, an analogous model is implied for each set of Fourier coefficients, which for
the j’th set is
Y ∗k(g,l)j = µgj + βgj(xk(g,l) − x¯) + ǫk(g,l)j . (2.1)
Component-specific estimates and tests may be carried out under the model
(2.1) using standard linear-regression methodology. To illustrate, Figure 2 dis-
plays scatterplots of Fourier coefficients corresponding to j = 1 in the left panel
and j = 41 in the right panel, with estimated region-specific fitted regression
lines drawn in. The former panel depicts patterns one would more-or-less expect
to see in these data. There, the Y ∗1k are seen to generally decrease as latitude
increases, as would be expected of measurements of yearly average-temperature.
Observe also that the Y ∗1k of the Atlantic and Continental stations follow a com-
mon trend fairly consistently, whereas those of the Pacific stations fall above
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Table 1
P-values for component-specific and global tests comparing the relationships between
temperature and latitude across regions. The headings “falls on common trend” and “same
slope” refers to the respective null hypotheses H0 : (µg1j − µ¯j) + (βg1j − β¯j)(x¯g1 − x¯) =
(µg2j − µ¯j) + (βg2j − β¯j)(x¯g2 − x¯) and H0 : βg1j = βg2j , where (g1, g2) is taken across all
pairs of distinct regions consistent with the row label. The headings Y ∗
1k
and Y ∗
41k
indicate
component-specific tests at j = 1 and j = 41, respectively, each with ν numerator degrees of
freedom. “Global” p-values are simulated from the null distribution of Fglobal.
Falls on common trend Same slope
Comparison ν Y ∗
1k
Y ∗
41k
Global Y ∗
1k
Y ∗
41k
Global
All regions 2 <0.001 <0.001 <0.001 0.480 <0.001 0.005
Atlantic to Pacific 1 <0.001 0.019 <0.001 0.881 <0.001 0.031
Atlantic to Continental 1 0.289 <0.001 <0.001 0.313 <0.001 0.003
Pacific to Continental 1 <0.001 <0.001 <0.001 0.454 0.510 0.180
that trend. The fitted slopes of all three regions are roughly the same. A very
different pattern is seen in the scatterplot of the Y ∗41k. Among those coefficients
it is seen that the Pacific and Continental stations follow roughly the same
trends, though shifted slightly, and that those trends are very different from the
trend followed by the Atlantic stations: the Y ∗41k tend to increase with latitude
for the former stations but decrease for the latter.
The pattern associated with the Y ∗41k within a yearly temperature profile
is symmetric with a period about two-and-a-half weeks. Its magnitude is quite
small, accounting for relative temperature differences of less than one half of one
degree. Yet our analysis suggests its relationship with latitude may distinguish
the Atlantic region from the others.
Formal tests of the patterns noted above may be formulated in terms of
the parameters of the model (2.1). Corresponding p-values are listed in Ta-
ble 1. To describe the relevant hypotheses, it will be convenient to define an
“overall” regression line at each j, REGj(x) = µ¯j + β¯j(x − x¯), where µ¯j =
M−1
∑
gM
3
g=1µgj and β¯j = M
−1
∑3
g=1Mgβgj . Referring to the headings of
Table 1, the null hypothesis labeled “falls on common trend” is H0 : (µg1j − µ¯j)
+ (βg1j − β¯j)(x¯g1 − x¯) = (µg2j − µ¯j) + (βg2j − β¯j)(x¯g2 − x¯) for (g1, g2) ∈ G,
for which x¯g = M
−1
g
∑Mg
l=1 xk(g,l), where the index-set G consists of all pairs of
distinct indices among regions indicated in the table’s corresponding row-label.
The null hypothesis labeled “same slope” is H0 : βg1j = βg2j for (g1, g2) ∈ G.
Each null hypothesis above may be written as a linear hypothesis H0 :
LTβj = 0, where βj = [µ1j , µ2j , µ3j , β1j , β2j , β3j]
T and L is a matrix of full
column-rank that is determined by the specific hypothesis. The associated test
statistic is a ratio of independent “mean-square” statistics Fj = MSj(L)/MSEj ,
which follows an F distribution whose non-centrality parameter is zero only
under H0, assuming the errors in (2.1) are independent, homoscedastic, and
Gaussian. (Explicit formulas are provided in Section 2.4; see also, Seber, 2003.)
Associated degrees of freedom are ν = rank L, whose values are indicated in
Table 1, and M − P = 25.
The p-values in Table 1 reflect the observations made above on Figure 2.
Comparing against the standard 0.05 level, the p-values in the column labeled
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Fig 3. P-values for component-specific tests of “same slope.” The null hypotheses are H0 :
βg1,j = βg2,j , for region indices (g1, g2) indicated above each plot. The vertical axis is on a
logarithmic scale; reference levels are indicated at α = 0.001 and α = 0.05.
Y ∗1k under “falls on common trend” separate out the Pacific region as falling off
of a common trend that is followed by the other regions. Those in the Y ∗1k column
under “same slope” indicate no evidence for differences in slope. Similarly, the
column labeled Y ∗41k under “same slope” separates out the Atlantic region as
having a different relationship with latitude than the others.
There remains the question of how to carry out these tests “globally.” That
is, can the same hypotheses be tested on the whole of the temperature profiles,
inasmuch as they are represented by 65 sets of Fourier coefficients? This type
of question is the central concern of this article. A starting point is to consider
the plots in Figure 3, which charts the p-values from component-specific tests
of “same slope” across all sets of Fourier coefficients, j = 1, . . . , 65, each panel
corresponding to a separate pair of regions. The most significant differences in
slope are reflected in the very small p-values displayed in the two leftmost panels,
at j = 41. Other p-values are “small” as well, in the sense of falling below the
0.05 level, even in the rightmost panel, but nowhere near as small as these two
at j = 41. However, in light of there being 65 test results to examine per panel,
it is no surprise to find at least a handful of small p-values. Of interest, then, is
to deduce a single assessment for each panel which combines the p-values across
all j = 1, . . . , 65.
Well suited to this task is a test statistic constructed by tapering, in a manner
similar to (1.4). For the present situation, let us define this statistic as Fglobal =∑65
j=1 wjFj , and set the weights to wj = j
−1/2, paralleling the construction of
QOPTn . By combining the individual test statistics Fj this way, Fglobal is globally
sensitive, but it down-weights the influence of the Y ∗jk with larger j, as is desired
to reflect primary interest in the larger-scale shapes.
Independence shall be assumed among the Y ∗jk across j (which is justified in
in Section 2.4), so that the null distribution of Fglobal is fully defined. Simulated
p-values (using one million iterations) for global versions of the null hypotheses
discussed above are listed in the columns of Table 1 labeled “global.” Comparing
against 0.05, those in the “same slope” portion of the table again separate
out the Atlantic region as having a different relationship with latitude than
the others, but this conclusion now accounts for essentially all aspects of the
temperature profiles.
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2.4. An asymptotic framework for functional data analysis
The sort of analysis carried out on the Canadian temperature data is now cast
in the general context described in Section 1. The transformation from the
continuous model (1.1) to the discrete model (1.2) will be laid out in detail,
and its properties discussed. Hereafter, the notation will revert back to that of
the replicated model, in which there is an explicit reference to a sample-size
parameter, n.
Regarding the setup for asymptotic analysis, there is some imprecision in
defining replication strictly according to the model (1.1), for the presence of
a continuous covariate would make it unrealistic to expect exact duplication
of the regressor matrix, X, except in carefully designed experiments. Absent
a continuous covariate, however, many multi-group experiments do allow the
parameterizationMg = Ngn, where Mg are group-specific sample sizes, and the
“sample size” n is some common divisor among them. In such cases the matrixX
would consist entirely of zeros and ones, and N =
∑
gNg. The notation adopted
in the Canadian temperature example is intended to suggest such a multi-group
experiment; yet, the corresponding replication concept is unrealistic, for if any
additional weather stations were sampled, one would not expect the latitudes
of those stations to match any of those in the current data set.
Such complications notwithstanding, the purpose of introducing the sample-
size parameter, n, is to manifest the notion that an increase in the amount of
data collected is coupled with a decrease in error variability. This is apparent in
expression (1.2), which shows the magnitude of error in the discrete model to
shrink at the rate n−1/2. Some readers might prefer to reinterpret the asymptotic
formulation used in this article to one in terms of shrinking errors, in which
case the results presented here would directly translate. Otherwise, a “pure”
interpretation of replication in the model (1.1) might take n = 1 in an analysis
of current data, and treat any future replication as entirely hypothetical; or,
one might employ various conceptual devices, such as sampling covariates from
a distribution, to modify the model (1.1) and its translation to (1.2) so as to
make replication more realistic. Despite these possibilities, the perspective taken
here is that the model (1.1) is entirely adequate for illustrating the key ideas of
present interest, and any modification would only add technical complications
that are tangential to them.
Regarding data collection and Fourier decomposition, the functional mea-
surements are assumed to have been taken along a dense, finite grid that is
common to all Y i(t), as in the Canadian temperature data. For t in the do-
main (a, b], the points of the grid are taken to be tl = a + (b − a)l/r for
l = 1, . . . , r and some fixed, large r (which may not be pn). The data associ-
ated with the curve Yi,k(t) are Yi,k(t1), . . . , Yi,k(tr). (In more general situations
the grid may change from curve to curve, but to avoid additional complica-
tion it will be assumed a good approximation to the present setup is available,
e.g., by interpolating measurements onto a fixed grid.) Set ψ1(t) = 1, ψ2j(t) =
sin(πj{2(t− a)/(b− a)− 1}), and ψ2j+1(t) = cos(πj{2(t− a)/(b− a)− 1}) for
j = 1, 2, . . . Writing Y ∗i,j = [Y
∗
i,j1, . . . , Y
∗
i,jN ]
T , the Fourier coefficients, Y ∗i,jk, are
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calculated by the formula
Y ∗i,j =
1
r
r∑
l=1
Y i(tl)ψj(tl). (2.2)
To make the final step to the discrete model (1.2), a linear transformation
involving L is used to tailor the statistics (2.2) to the linear hypothesis. Set
H = {LT (XTX)−1L}−1/2 and define the Y n,j in (1.2) according to
Y n,j =
1
σjn
n∑
i=1
HLT (XTX)−1XTY ∗i,j , (2.3)
where σ2j = V [Y
∗
i,jk]. The remaining objects defining (1.2) are
θj =
1
σjr
r∑
l=1
HLTβ(tl)ψj(tl) and (2.4)
en,j =
1
σjr
√
n
n∑
i=1
r∑
l=1
HLT (XTX)−1XT ǫi(tl)ψj(tl).
An often-appropriate assumption has each ǫi a stationary process such that
ǫi,k(tl) =
∑
∞
m=−∞ γm ηi,k(tl − (b − a)m/r), for which ηi,k(a + (b − a)m/r)
is, across integer m, a mean-zero independent and identically distributed se-
quence with finite fourth moment, and
∑
∞
m=−∞ |γm| < ∞. When this assump-
tion is valid, Theorem 10.3.2.i of Brockwell and Davis (1991) implies that each
Cov(Y ∗2i,jl, Y
∗2
i,kl) → 0 as r → ∞, for j 6= k. (See also Corollary 3.1.1.i in Sec-
tion 3, below.) Thus, Fourier decomposition provides a means to decorrelate
the functional linear model, while the statistics (2.2) or (2.3) capture its core
structure.
In the typical case where the σ2j are unknown, the test statistic Qn in (1.4)
would be replaced by Qˆn = n
∑pn
j=1 wj‖Yˆ n,j‖2, where Yˆ n,j is defined as in the
right side of (2.3) but with an estimate σˆ2n,j substituting for σ
2
j . For instance,
the σˆ2n,j may be the usual unbiased estimates
σˆ2n,j =
1
(nN − P )
n∑
i=1
N∑
k=1
(Y ∗i,jk − xTk βˆ)2, (2.5)
where
βˆ =
1
n
n∑
i=1
(XTX)−1XTY ∗i,j .
This modification led to the statistic Fglobal in the Canadian temperature ex-
ample, for which Fj = MSj(L)/MSEj has
MSj(L) = n
−1
n∑
i=1
HLT (XTX)−1XTY ∗i,j/ν and MSEj = σˆ
2
n,j ,
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so that Fglobal =
∑pn
j=1 wjFj = Qˆn/ν. Fan and Lin (1998, sec. 3.4) discuss other
estimates of σ2j based on smoothing across j, which are specialized for the Fourier
decomposition technique.
Regarding the relationship between pn and n, the reader should notice that
pn never appears in the transformation from (1.1) to (1.2), and so these two
parameters are never actually connected. The parameter pn is constrained by
the resolution of the grid t1, . . . , tr, which to avoid numerical error requires
pn ≤ r. Moreover, it is possible that pn would be set according to subjective
modeling assumptions such as an analyst’s determination of the number of basis
functions needed to describe the data, as was made in the Canadian temperature
example. In Spitzner, Marron, and Essick (1998), pn is set subjectively to avoid
observed defects in the ability of the ψj to decorrelate the model at larger
j. At any rate, the justification for taking n → ∞ and pn → ∞ is that it
forms an appropriate abstract conceptualization for repeated measurement of
functional data in accordance with a global point of view. In particular, pn →∞
represents a situation where the grid t1, . . . , tr is to become increasingly dense,
and if n→∞ as well then potentially all available information about the curve
model will be captured in the limit.
3. Rates of testing for the tapering mechanism
The discussion now turns to rates-of-testing theory and the asymptotic opti-
mality of QOPTn among tests based on tapering. The more technical aspects of
this discussion have been omitted, but can be found in Spitzner (2008A).
Smoothness constraints are formally defined within rates-of-testing theory as
a restriction of the functional parameter β(t) in (1.1) to a smooth-function class.
In the most general settings, this would be a Besov class, but here it is taken
to be a Sobolev class, a special case, which is appropriate when working with
Fourier decompositions. Such constraints may be expressed as a restriction of
the mean vectors of the discrete model (1.2) to the geometry
Bs,M =

(θ1, θ2, . . .) :
√√√√
∞∑
j=1
j2s‖θj‖2 ≤M

 , (3.1)
a Sobolev ellipsoid of radius M in infinite-dimensional discrete space, where
M > 0 and s > 1/2 are fixed constants. The notation s˜ = 4s + 1 > 3 shall
also be used. The bound on the norm in (3.1) models smoothness by restrict-
ing expression of the higher-indexed θj , with larger s making the restriction
stronger. Moreover, Parseval’s identity implies that (θ1, θ2, . . .) ∈ Bs,M is equiv-
alent to the assumption that the corresponding β(t) in (1.1), assuming the θj
arise through (2.4), is an element of a Sobolev ellipsoid in continuous space,
{β(t) = [β1(t), . . . , βP (t)]T : ‖
∫ 1
0 β
(sc)
k (t)dt‖ ≤ Mc} for some sc = 1, 2, . . . and
Mc > 0, which are easily determined. (For details and further discussion, see
Adams and Fournier, 2003).
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The “rates” in rates-of-testing theory, which characterize test performance,
are described as follows. Fix s > 1/2, M > 0, and for each n let φn =
φn(Y n,1, . . . ,Y n,pn) be a test of (1.3) such that limn P0[φn = 1] ≤ α, for a
fixed level α ∈ (0, 1). The notation Pθ is here used to denote probabilities un-
der the model (1.2) for a specific θ = (θ1, θ2, . . .) and fixed n. Rates-of-testing
criteria are formulated from sequences δn → 0 satisfying
inf
θ∈H1(δn/δ∗n;s,M)
Pθ[φn = 1]→ 1 for every δ∗n → 0, (3.2)
where
H1(δ; s,M) =

θ ∈ Bs,M :
√√√√
∞∑
j=1
‖θj‖2 ≥ δ

 . (3.3)
The criterion (3.2) describes the rate at which a gap may shrink between the
null hypothesis and a class of “distinguishable” alternatives, those the test would
be able to detect with high power, asymptotically. The better-performing tests
allow this gap to shrink faster: if for some δn → 0 the criterion (3.2) is satisfied
for one test, but not another, the former test is preferred.
Ingster’s (1993) minimax performance bound states that for no test does any
δn = o(n
−2s/s˜) satisfy (3.2), but there is a test (based on tapering) for which
δn = n
−2s/s˜ satisfies (3.2). This identifies the rate δˆMn (s) = n
−2s/s˜ as minimax
for the geometry Bs,M at a specific s. Suppose now that fixed bounds s∗ < s∗
are given, and for each s∗ < s < s
∗ one is to consider a separate sequence
(δn(s)), and set δˆ
AM
n (s) = {n2(log logn)−1}−s/s˜. Spokoiny (1996) establishes
that for no test is (3.2) satisfied across s∗ < s < s
∗ if δn(s) = o(δˆ
AM
n (s)) for
some such s. It is also shown there is a test (based on thresholding) for which
δn(s) = δˆ
AM
n (s) does satisfy (3.2) across s∗ < s < s
∗. This identifies the rates
δˆAMn (s) as adaptive-minimax for Bs,M across s∗ < s < s∗. (The optimal tests
alluded here are the same mentioned in Section 1 and are described later in
Section 4.)
The main technical result for evaluating tests based on tapering rewrites the
criterion (3.2) in terms of the parameters of the test statistic (1.4).
Theorem 3.1. Assume the model (1.2) and suppose (Qn) is a sequence of test
statistics with each Qn as in (1.4) for associated sequences (wn,j) and (pn) such
that each 0 < wn,j ≤ 1 and pn →∞ as n→∞. Set Sn(p) = w2n,1 + · · ·+ w2n,p,
Wn(p) = min{w2n,j : j ≤ p}, Un(p, q) = qWn(q)/Sn(p), and Un(p) = Un(p, p).
Suppose at each n the en,jk are independent across k, and
∣∣∣∣∣∣
V

n
pn∑
j=1
wj‖Y n,j‖2

− n2
pn∑
j=1
w2n,jV [‖Y n,j‖2]
∣∣∣∣∣∣
= O(Sn(pn)). (3.4)
Suppose further that each en,jk is such that E[en,jk] = 0, V [en,jk] = 1, E[e
4
n,jk]
≍ 1 uniformly across j, k, and n, and P [en,jk ≤ −t] > 0 for each t > 0. Let
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(δn) be some positive sequence for which δn → 0. Fix α and, for each n, let φQn
denote the size-α test which rejects the null hypothesis in (1.3) when Qn exceeds
some critical value. For fixed s > 1/2, M > 0, and φn = φ
Q
n the criterion (3.2)
holds if, and only if, both
(i.) lim sup
n→∞
n2Un(pn)p
−s˜
n <∞ and (3.5)
(ii.) lim inf
n→∞
n2Un(pn, qn)q
−s˜
n > 0,
where qn = {δn/M}−1/s. The same conclusion holds if the Yn,jk in Qn are
replaced with Yn,jk(1+op(1)), provided Cov(Y
2
n,jk(1+op(1)), Y
2
n,jl(1+op(1)))→
Cov(Y 2n,jk, Y
2
n,jl) for each j, k, and l.
Proof. This is Theorem 1 of Spitzner (2008A).
An important corollary of this theorem establishes its validity under assump-
tions on the covariance structure of the continuous model (1.1) that would typ-
ically be made in practice. The case of unknown variances is also treated.
Corollary 3.1.1. Suppose the model (1.2) derives from the functional linear
model (1.1) via the transformation (2.3), and assume the notation of Section
2.4. The conclusions of Theorem 3.1 hold true under the following statement (i)
and remain true under statement (ii).
(i) Each ǫi in (1.1) is such that ǫi,k(tl) =
∑
∞
m=−∞ γm ηi,k(tl−(b−a)m/r),
for which the coefficients γm satisfy
∑
∞
m=−∞ |γm||m|1/2 < ∞, the ηi,k(a+
(b − a)m/r) are independent and identically distributed across integer m
with E[{ηi,k(a+(b− a)m/r)}4] <∞, and the weight sequence (wn,j) does
not increase in j for each n.
(ii) Qn is replaced by Qˆn, substituting for σ
2
j the usual unbiased estimates
σˆ2n,j, defined in (2.5).
Proof. Under the conditions of statement (i), and assuming pn ≤ r, Theorem
10.3.2.ii of Brockwell and Davis (1991) implies that pnCov(Y
∗2
i,jl , Y
∗2
i,kl) is uni-
formly bounded across j, k = 1, . . . , pn with j 6= k. From this comes the prop-
erty Cov(Y 2n,jl, Y
2
n,kl) < B/(n
2pn) for some B across j, k = 1, . . . , pn with j 6= k.
Thus, if (wn,j) is as indicated, one has
n2
pn−1∑
j=1
pn∑
k=j+1
ν∑
l=1
wn,jwn,kCov(Y
2
n,jl, Y
2
n,kl)
≤ Bν
pn
pn−1∑
j=1
(pn − j)w2n,j ≤ BνSn(pn),
and so the criterion (3.4) is satisfied. Statement (ii) is readily verified using the
delta rule to show that E[σˆ−2n,j ]→ σ−2j , Cov(σˆ−2n,j , σˆ−2n,k)→ 0, and Cov(Yn,jk , σˆ−2n,j)
→ 0, from which it follows that Cov(Yˆ 2n,jk , Yˆ 2n,jl) → Cov(Y 2n,jk , Y 2n,jl).
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In Spitzner (2008A), Theorem 3.1 is applied to characterize and bound the
rates-of-testing performance of tests based on tapering. The key results most
relevant to present purposes are summarized as follows.
Corollary 3.1.2. Assume the notation and conditions of Theorem 3.1.
(i) Suppose (3.5.i) holds and δˆn → 0 is such that n2Un(pn, qˆn)qˆ−s˜n ≍ 1,
where qˆn = {δˆn/M}−1/s. Then, the sequence (δˆn) defines a “boundary
rate” of the test φQn in the sense that for any sequence (δn) the criterion
(3.2) holds if δˆn = O(δn) but not if δn = o(δˆn).
(ii) Set δˆQn (s) = {n2(logn)−1}−s/s˜ and suppose 1/2 < s∗ < s∗. For no test
φQn is (3.2) satisfied for δn = o(δˆ
Q
n (s)) across s∗ < s < s
∗. Moreover, if
wn,j = j
−1/2, as in QOPTn , and pn is such that {n2(logn)−1}1/3/pn is
bounded and log pn ≍ logn, then φQn satisfies (3.2) for δn = δˆQn (s) across
s∗ < s < s
∗. Thus, δˆQn (s) is an “optimal adaptive rate of testing for the
tapering mechanism.”
Proof. Statement (i) and the first assertion of (ii) follow immediately from The-
orems 2 and 3, respectively, of Spitzner (2008A). To prove the second assertion
of (ii), first observe that the specified settings imply {n2(log n)−1}1/s˜/pn is
bounded, since s˜ > 3, and Sn(pn) ≍ log pn. It follows that the sequence in
(3.5.i) has
n2Un(pn)p
−s˜
n ≍ n2p−s˜n / log pn = {(logn)/(log pn)}
[
{n2(logn)−1)}1/s˜/pn
]s˜
,
which is bounded. Next set δn = δˆ
Q
n (s), so that qn = M
1/s{n2(logn)−1)}1/s˜,
and observe
n2Un(pn, qn)q
−s˜
n ≍ n2q−s˜n / log pn =M−s˜/s(logn)/(log pn).
Thus the conditions of statement (i) hold, and δˆQn (s) is a boundary rate for this
test.
The first statement of Corollary 3.1.2 is useful to deduce the δn → 0 such
that (3.2) holds for a specific test, as is demonstrated in the proof of the second
statement. The second statement is particularly important in that it establishes
the concept of adaptive optimality among tests based on tapering, and charac-
terizes the associated performance bound via the sequence δˆQn (s). Observe that
the optimal adaptive rate identified in that statement is slower than Spokoiny’s
adaptive-minimax rate, δˆAMn (s) = o(δˆ
Q
n (s)). This of course means there are tests
that would asymptotically outperform any test based on tapering in the adaptive
context, such as Spokoiny’s (1996) test based on thresholding or Fan’s (1996)
adaptive Neyman test. Nevertheless, within the class of tests based on tapering,
the test based on QOPTn , with pn as in Corollary 3.1.2.ii, is adaptively optimal.
Moreover, although the condition log pn ≍ logn does not allow pn → ∞ at
an arbitrarily fast rate, it nevertheless gives the dimensionality parameter fairly
wide leeway. This property makes such a test particularly suited for use in FDA.
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Let us also remark that adaptive-optimality can be established in the same
manner as in the proof of Corollary 3.1.2.ii for the class of test statistics (1.4)
with wn,j = {j(log j)γ}−1/2 such that γ < 1. The setting γ = 0, the special case
that defines QOPTn , is preferred for simplicity.
4. Comparisons among high-dimensional tests
In this section, the various high-dimensional tests alluded to in this article are
described in detail and evaluated by simulation, with the goal of comparing the
power-properties of tapering, truncation, and thresholding mechanisms.
The tests are defined here in the context of the discrete model (1.2), tak-
ing ν = 1, and are compared assuming independent, Gaussian errors with
known variances. Indeed, most of the available theoretical results are derived
in this context, including those of Ingster (1993) and Spokoiny (1996). (Yet
Fan and Lin, 1998, and Fan and Huang, 2001, establish robustness of the good
power-properties of Fan’s, 1996, adaptive Neyman test under weaker assump-
tions.) To reflect the setting ν = 1, this section will revise notation to rewrite
Y n,j = Yn,j , θn,j = θn,j , and en,j = en,j in (1.2). Each test is defined below by
stating a test statistic; it should be assumed the corresponding test itself rejects
the null hypothesis when the test statistic exceeds a fixed cutoff.
4.1. Tests based on tapering
A test based on tapering that is known to achieve Ingster’s minimax rate is
defined by the test statistic FZZn = n
∑pn
j=1 wn,jY
2
n,j , with weights given
by wn,j = 1 − j4sξ2n/(1 + j2sξn)2 and ξn = n−4s/s˜. Optimal performance of
this test was first deduced in Fan, Zhang, and Zhang (2001) for a slight vari-
ation in which the test statistic is expressed as an infinite quadratic form,
FZZ∞n = n
∑
∞
j=1 wn,jY
2
n,j . However, Spitzner (2008A, ex. 2) clarifies that such
performance is retained for the finite-sum version, provided n2/s˜ = O(pn).
A minimax test based on a more simple quadratic form is studied in Ingster
(1993). It is defined by the unweighted statistic UWQn = n
∑pn
j=1 Y
2
n,j , and has
δˆMn (s) = n
−2s/s˜ as a boundary rate, provided pn ≍ n2/s˜. A pitfall of this test
is that it is extremely sensitive to the rate at which pn increases, which puts
it at a serious disadvantage in the FDA context. For instance, if pn ≍ n2/γ
for γ 6= s˜ it is possible to find sequences δn = n−(2−t)s/s˜ with t > 0 that
fail to satisfy the rates-of-testing criterion (3.2). This is a drastic degradation
in performance, well beyond that incurred to achieve adaptive-minimaxity or
optimal adaptive performance among tests based on tapering. The power of the
test based on UWQn is invariant on the contours of
∑pn
j=1 θ
2
n,j , a property that
is sometimes touted as a practical advantage; for present purposes this property
will be exploited to calibrate the simulation design.
Note that tests based on FZZn, FZZ
∞
n , and UWQn each require a precise
specification of the parameter s to achieve minimax performance. Consequently,
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since s can rarely be specified exactly, each is difficult to implement in practice.
In the present exercise, these particular tests should be regarded not as candi-
dates for practical usage, but as conceptual references against which to compare
the properties of other tests.
Two other tests based on tapering will also be evaluated. One is, of course,
that based on QOPTn , an adaptively optimal test of this class. The other is
defined by the test statistic CVMn = n
∑pn
j=1 j
−2Y 2n,j , which is motivated by
the classical Crame´r-von Mises statistic of goodness-of-fit testing. The Crame´r-
von Mises statistic is traditionally expressed as in integrated squared-difference
between empirical and hypothesized distribution functions, but it is studied
in Eubank and LaRiccia (1992) via the representation n
∑pn/2
j=1 j
−2(Y 2n,2j−1 +
Y 2n,2j), giving rise to the statistic CVMn studied here. This test is included as
an example of a widely-used high-dimensional test that exhibits rather poor
performance in an FDA context. For instance, it can be shown that, due to its
strong down-weighting of higher-indexed components, its best possible boundary
rates are δˆn = n
−(2−t)s/s˜ for t = 2{1− s˜/(s˜+ 3)} > 0.
4.2. Adaptive-minimax tests based on truncation and thresholding
Two tests that achieve Spokoiny’s adaptive-minimax rate shall be considered,
one based on truncation and the other on thresholding. The test based on trun-
cation is Fan’s (1996) adaptive Neyman test, whose test statistic is ANn =
maxk=1,...,pn(Nn,k − k)/
√
k, for which Nn,k = n
∑k
j=1 Y
2
n,j . Sometimes this test
is interpreted via the scheme known as “Neyman’s truncation,” which describes
the test statistic by Nn,kˆn , viewing kˆn as a data-driven diagnostic; to yield
ANn, kˆn is that k which maximizes the standardized sums (Nn,k−k)/
√
k. Other
choices of kˆn are discussed in Raynor and Best (1989), Eubank and Hart (1992),
Eubank and LaRiccia (1992), Inglot and Ledwina (1996), Eubank (2000), Aerts,
Claeskens, and Hart (2000), Claeskens and Hjort (2004), and elsewhere. Among
them, the test based on ANn has the most well established rates-of-testing prop-
erties and compares the most favorably in the empirical-power investigation of
Spitzner (2006), which is similar to the investigation carried out in what follows.
It is shown in Fan, Zhang, and Zhang (2001) to achieve Spokoiny’s adaptive-
minimax rate, at least for the case where pn = n.
The test studied here based on thresholding is introduced in Spokoiny (1996).
This test is readily applicable under the discrete model (1.2), but its formula-
tion takes the continuous model (1.1) to have been translated to (1.2) using
wavelet decomposition rather than Fourier decomposition. For present purposes
it is unnecessary to describe the complete details of that translation, except
to note that its organization of component-subscripts uses “wavelet indexing:”
j = j(k, l) denotes the l’th component at the k’th level of resolution: k = 0, 1, . . .
and l = 1, . . . , 2k; j(0, 1) = 1, j(k+1, l) = j(k, l)+2k, and j(k, l+1) = j(k, l)+1.
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The test statistic is constructed in two stages. In the first stage, a class of
tests indexed by s > 1/2 is constructed as follows. Define
HTn(s) =
k∗n(s)∑
k=0
2k∑
l=1
[
nY 2n,j(k,l) − 1
]
(4.1)
+
k∗n∑
k=k∗n(s)+1
2k∑
l=1
[
nY 2n,j(k,l)I{
√
nYn,j(k,l) > ξn,k(s)} − µHT (ξn,k(s))
]
for parameters k∗n(s), k
∗
n, and a “hard-thresholding” parameter ξn,k(s), where
µHT (ξ) = E[η
2I{|η| > ξ}] with η following a standard-normal distribution. The
settings applied here take k∗n = ⌈log2 n⌉, k∗n(s) = ⌈(2s + 1/2)−1 log2 n⌉, and
ξn,k(s) =
√
(k − k∗n(s) + 8) log 2, where ⌈x⌉ denotes the smallest integer still
to exceed x. In the second stage, a range s∗ < s < s
∗ is assumed to have been
specified, over which adaptively-optimal performance is to be achieved. The
HTn(s) corresponding to s in that range are combined into the test statistic is
HTn = maxs∗<s<s∗ HTn(s)/cn,α(s), where cn,α(s) is the cutoff for a size-α test
based on HTn(s). (Note there is only a finite number of distinct HTn(s) across
s∗ < s < s
∗.)
The settings for k∗n(s) and ξn,k(s) given above are not those originally
specified in Spokoiny (1996), but are modified versions suitable for the non-
asymptotic context considered here. The original settings are k∗n(s) = ⌈(2s +
1/2)−1 log2(Mn)⌉, where M is as in Bs,M , and the hard-thresholding param-
eter is ξn,k(s) = 4
√
(k − k∗n(s) + 8) log 2. With these, Spokoiny (1996) estab-
lishes that each test based on HTn(s) achieves Ingster’s minimax rate, and
the test based on HTn achieves Spokoiny’s adaptive-minimax rate. However,
Abramovich et al. (2002) remark that in the original setting for ξn,k(s) the
leading constant of four is “unreasonably high” for “finite sample situations,”
presumably referring to data configurations one would tend to work with in
practice, and proposed it be replaced with one, as is done here. The original
setting for k∗n(s) is problematic in that it depends on M . Abramovich et al.
(2002) handle this with application-specific, ad hoc adjustments; the setting
here matches the ratio k∗n/k∗n(s) to the limit of what it would be under the
original setting.
4.3. An empirical comparison
The power of the tests described in Sections 4.1 and 4.2 are now compared
in a simulation exercise involving two classes of high-dimensional alternatives.
The first class consists of “spiked” alternatives, for which θj is taken to have
θj =
√
λ for j = j0 and θj = 0 otherwise, where j0 is a subscript that indexes
the class, and λ is set to calibrate each alternative so that the power of the
test based on UWQn is 0.4. The second class consists of “smooth” alternatives,
which are parameterized according to θj =
√
λ{1− j/(pn + 1)}d/c where c2 =∑pn
j=1 θ
2
j , d = {log 0.2/ log(1 − b) − 1}/2 for 0 < b < 1, and λ is as in the
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Fig 4. Simulated power for high-dimensional tests against spiked and smooth alternatives.
Power curves associated with FZZn are marked by solid lines with circles (◦), those with
UWQn by dotted lines, those with QOPTn by thick solid lines, those with CVMn by dashed
lines, those with ANn by solid lines with dots (•), those with HTn by solid lines with squares
(). Insets display the shapes of example alternatives, with corresponding index values.
spiked class of alternatives. This formula is derived from the inverse-CDF of the
beta distributions, and is such that the partial sum
∑J
j=1 θ
2
j is approximately
80% of its value at J = pn when J is approximately 100b% of pn. The class is
indexed by the parameter b. Examples of each type of alternative are displayed
as upper-right insets in the panels of Figure 4.
Each spiked-alternative satisfies the technical property of maximally com-
pressing non-zero components into higher indices among alternatives with con-
stant
∑
∞
j=1 j
2sθ2j . Mathematical proofs of minimaxity single out these alterna-
tives as yielding the minimum power, which is to be maximized (cf. th. 4 of
Fan, Zhang, and Zhang, 2001, and th. 1 of Spitzner, 2008A). In other words,
the class of spiked alternatives represent those alternatives that are the hard-
est to distinguish. These may be of primary interest in some specialized FDA
applications, such as those involving PET-fMRI images (cf. Abramovich et al.,
2002). On the other hand, alternatives in the smooth class are idealized repre-
sentations of those of primary concern in more typical FDA testing problems.
For instance, in the Canadian temperature example, interest centers on such
large-scale attributes as the average yearly temperature and the differential be-
tween winter and summer temperatures, attributes that are expressed in the
lower-indexed θj . The smooth alternatives reflect this and similar situations by
expressing the departure from the null hypothesis mainly through these low-
indexed components.
The simulation design is such that the models examined each have dimension-
ality pn = 127, which was selected to accommodate seven levels of resolution
in the wavelet-indexing scheme, at k = 0, 1, . . . , 6. (This value is not atypi-
cal in FDA applications; e.g., pn = 100 in Fan and Lin, 1998, and pn = 124
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in Spitzner, Marron, and Essick, 1998.) The sample-size parameter is set to
n = 64, which was chosen since the statistic HTn then has k
∗
n = 6, so that
the test is sensitive to all available levels of resolution.
Simulated power is calculated at twenty alternatives from each of the spiked-
and smooth-alternative classes. The specific alternatives evaluated are such that
their corresponding class indices are roughly evenly-spaced across the ranges
j0 = 1, . . . , pn for the spiked class and 0.01 ≤ b ≤ 0.80 for the smooth class,
including the stated endpoints.
Some intricacy is required to deduce reasonable specifications for the pa-
rameters of the Sobolev geometry, Bs,M , which are needed to construct the
statistics FZZn and HTn. For spiked alternatives, the bound in Bs,M is set to
M = λ(pn+1), so that the Sobolev norm of the alternative indexed at j0 = pn+1
would have
∑
∞
j=1 j
2sθ2j = M at s = 1/2, if such a setting for s were allowed.
Then fixing M at this value, the parameter s is set at different values for differ-
ent alternatives: for j0 = 2, . . . , pn, the parameter is s = log(pn + 1)/{2 log j0},
which solves
∑
∞
j=1 j
2sθ2j = M ; for j0 = 1, s is set to its value at j0 = 2.
For smooth alternatives, M is first set to the value
∑pn
j=1 j
2sθ2j obtained with
s = 1/2 and the θj defined by indexing at b = 0.81. The parameter s is then set
numerically at each alternative evaluated, for which b ≤ 0.80, to the value that
solves
∑
∞
j=1 j
2sθ2j =M .
The bounds s∗ and s
∗, which are required to construct HTn, are taken as
the lower and upper values of s calculated in the scheme above, treating the
two classes of alternatives separately. The selected spiked alternatives yield the
bounds s∗ = 0.5008 (at j0 = 127) and s
∗ = 1.1667 (at j0 = 1); the selected
smooth alternatives yield s∗ = 0.5017 (at b = 0.80) and s
∗ = 2.4680 (at b =
0.01). Under these settings, the parameter k∗n(s) varies within a very narrow
range: k∗n(s) = 4, 5 for spiked alternatives, and k∗n(s) = 3, 4, 5 for smooth
alternatives. Consequently, the simulated power of the test based on HTn is
nearly identical to that of each test based on HTn(s).
Simulated power curves are displayed in the panels of Figure 4 for tests based
on FZZn, UWQn, Q
OPT
n , CVMn, ANn, and HTn. Test-statistic cutoffs and
the quantities µHT (ξn,k(s)) of the statistic HTn were calculated by simulation,
and all tests were carried out at the α = 0.05 level. Every simulation used a
minimum of 250,000 iterations. The left panel of Figure 4 displays results for the
spiked alternatives, and the right panel those of the smoothed alternatives. One
should find that the test based on UWQn serves well as a basis of comparison
for the other tests, observing that its simulated power curve is near-constant at
the value 0.4.
Examining first the results for spiked alternatives displayed in the left panel,
the benefit of the test based on HTn against spiked alternatives is glaring.
Whereas the simulated power curve of every other test follows the same pattern
of starting out high at low values of j0 then dropping sharply and later evening
out well below 0.4, that of HTn is nearly flat at 0.6, representing a consistent
50% increase in power above that of the test based on UWQn. Among the
remaining tests, the simulated power curves of the tests based on FZZn, Q
OPT
n ,
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and ANn appear quite similar, and reflect performance that is not altogether
poor, especially at the lower values of j0. The test based on CVMn, however,
exhibits exceptionally poor performance.
The picture changes drastically for the smooth alternatives. In the right panel,
the considerable advantage of the test based on HTn against spiked alternatives
disappears; its simulated power, in fact, appears generally low relative to the
other tests, and the same can be said of the test based on ANn, although
to a lesser degree. To put it another way, it is the tests based on tapering
that exhibit superior performance in this context, specifically those based on
FZZn and Q
OPT
n . The test based on FZZn outperforms that based on Q
OPT
n ,
and this is not altogether surprising given that the former satisfies a stronger
asymptotic property. Simulated power of the test based on CVMn is still quite
poor, although not as dismal as it is for spiked alternatives.
Though the tests based on truncation and thresholding are known to have
superior asymptotic performance, these empirical results suggest quite clearly
that the higher-order asymptotic factors wash out slowly, and may very well
have a substantial influence in data configurations one is likely to encounter in
practice. All of the tests are shown to be sensitive to the shape of the alternative,
and the test based on thresholding appears especially sensitive in this regard.
These observations substantiate a recommendation to the analyst that when
choosing among high-dimensional test in FDA it is prudent to consider the
types of departures from the null hypothesis one is most interested in detecting.
The test based on QOPTn may best suit the goals of the analysis, despite its
asymptotic inferiority to truncation and thresholding, and it likely will in typical
FDA applications where the primary interest is in the large-scale attributes of
the model.
Let us briefly return to an observation made in the Canadian temperature
example. As has been suggested, the focus on large-scale attributes puts the
goals of the analysis in line with detecting smooth-shaped alternatives, and, in
light of the current simulation results, the test based on Fglobal is best suited to
that purpose. However, recall that the test rejected H0 on the example data, and
exploratory analysis indicated the presence of a spiked-shaped alternative. Thus
we have a practical illustration of a test based on tapering evidently detecting an
alternative among those hardest to distinguish, thereby further demonstrating
the global power of the test.
5. Concluding discussion
Through an application example and both theoretical and empirical power in-
vestigations, this article has demonstrated the benefits of the tapering mech-
anism in FDA, and the test based on QOPTn in particular. It has been shown
how tests based on tapering may be constructed on a functional linear model,
using Fourier decomposition to first translate to a high-dimensional discrete
model. Intuition for the discrete model and tests based on tapering have been
discussed through an example analysis of the Canadian temperature data. Ap-
plying criteria from rates-of-testing theory, it has been shown that the weight
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setting wn,j = j
−1/2 in (1.4), which defines QOPTn , represents an adaptively
optimal configuration among tests based on tapering. Moreover, the test based
on QOPTn retains optimality over a wide range of rates at which pn → ∞, a
property that is particularly advantageous in the FDA context. The discussion
reiterates that any test based on tapering can be outperformed asymptotically
by tests based on truncation or thresholding. Nevertheless, an empirical inves-
tigation in a non-asymptotic context has demonstrated that high-order effects
may be non-negligible in practice, and that the test based on QOPTn has superior
power against a class of alternatives that would be of natural interest in many
FDA applications.
While this article argues in support of the tapering mechanism on the basis
of its power properties, there are a number of reasons completely separate from
power why an analyst would, at the outset, want to restrict himself or herself to
tests based on tapering. The first is that the test statistic (1.4) may arise through
a formal Bayesian construction, as a monotone transformation of a posterior null
probability. This is shown in Spitzner (2008B), where the rates-of-testing frame-
work is developed entirely within a Bayesian context. It should be noted that
there are existing Bayesian constructions of the thresholding mechanism for use
in estimation, e.g., in Abramovich et al. (2007), which suggest the statistic HTn
might be viewed as a summary metric applied a Bayesian estimator. This falls
short of producing a formal Bayesian test based on HTn, however, since it fails
to represent HTn as a monotone transformation of a posterior null probability.
Another reason that the tapering mechanism is attractive is because of its
straightforward intuition. The non-expert, once appreciating the goal to ex-
ploit smoothness but still retain global power, would more quickly embrace the
intuition underlying the use of tapering before truncation or thresholding. Ta-
pering is easy to understand as it directly incorporates all components of the
model, while explicitly down-weighting the high-indexed ones. The latter mech-
anisms are more complicated, harder to connect to the goal, and easy to apply
incorrectly. For these reasons, tapering may be the preferred recommendation
in consulting or interdisciplinary situations, and may offer the best insurance
for continued correct implementation once the statistician’s involvement in a
project wanes.
Finally, the test statistic (1.4) is convenient in that it may be treated through
well-known analytical approximations (see, e.g., Mathai and Provost, 1992, sec.
4.6), rather than simulation. This may be a trivial advantage in straightforward
testing problems, given modern computing power, but it can help enormously
when developing more complicated high-dimensional statistical procedures. For
instance, Spitzner and Marshall (2009) make critical use of distributional ap-
proximations of quadratic forms to develop a high-dimensional sequential mon-
itoring procedure based on tapering.
The results of this article encourage the use of the test based on QOPTn in
FDA, and establish a role for the tapering mechanism in rates-of-testing theory.
It is hoped that the ideas presented here are also found helpful in clarifying the
role of smoothness constraints in high-dimensional problems, and in providing
an accessible methodology with which to exploit them.
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